1. "2011"
Formats
  1. Journal Article (2141)
  2. Meeting Abstract (988)
  3. Book Section (224)
  4. Conference Paper (18)
  5. Book Whole (11)
Groups
  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)

More Groups

People
  1. Robert Soslow (64)
  2. Clifford Hudis (60)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (47)

More People

Years
  1. 2011 (3382)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (450)
  2. American Society of Clinical Oncology (327)
  3. Springer (231)
  4. American Association for Cancer Research (180)
  5. Nature Publishing Group (157)
  6. Wiley Blackwell (154)

More Publishers

Results (3382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of a single nucleotide polymorphism related to late toxicity in a randomized hypofractionation trial for prostate cancer
    Meeting Abstract

    Oh, J.; Deasy, J.; Stoyanova, R.; Saleh, Z.; Buyyounouski, M.; Wong, H. P.; Apte, A. P.; Price, R. A.; Hu, J.; Pollack, A.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: A randomized, double-blind, placebo-controlled phase III study
    Journal Article

    Ohtsu, A.; Shah, M. A.; Van Cutsem, E.; Rha, S. Y.; Sawaki, A.; Park, S. R.; Lim, H. Y.; Yamada, Y.; Wu, J.; Langer, B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • The tyrosine kinase inhibitor nilotinib protects the liver from ischemia/reperfusion (I/R) injury
    Meeting Abstract

    Ocuin, L.; Cavnar, M.; Sorenson, E.; Bamboat, Z.; Popow, R.; Zeng, S.; DeMatteo, R. P.
    Hepatology (2011)

    Fulltext@MSK | Save
  • Relationship between statin use and colon cancer recurrence and survival: Results from CALGB 89803
    Journal Article

    Ng, K.; Ogino, S.; Meyerhardt, J. A.; Chan, J. A.; Chan, A. T.; Niedzwiecki, D.; Hollis, D.; Saltz, L. B.; Mayer, R. J.; Benson, A. B. 3rd; more...
    JNCI: Journal of the National Cancer Institute (2011)

    Fulltext@MSK | Save
  • Late radiation toxicity after conformal radiotherapy for prostate cancer among patients with diabetes mellitus
    Meeting Abstract

    Novak, C. J.; Pei, X.; Kollmeier, M.; Cox, B.; Zelefsky, M. J.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Assessment of progression-free survival as a surrogate endpoint for overall survival in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Negrier, S.; Bushmakin, A. G.; Cappelleri, J. C.; Charbonneau, C.; Sandin, R.; Michaelson, M. D.; Figlin, R. A.; Motzer, R. J.
    European Journal of Cancer (2011)

    Fulltext@MSK | Save
  • Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma
    Meeting Abstract

    Mutter, R. W.; Lok, B.; Dutta, P. R.; Setton, J.; Berry, S.; Goenka, A.; Rao, S. S.; Wolden, S.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Identification of homologous recombination (HR) defects and biomarkers of response in sporadic breast cancer (BC)
    Meeting Abstract

    Mutter, R. W.; Bindra, R. S.; Park, J.; Powell, S. N.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Pilot project for comprehensive chart rounds using a telemedicine platform
    Meeting Abstract

    Mueller, B. A.; Obcemea, C.; Tumati, V.; Devita, F.; Song, Y.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Prognostic factors for progression-free survival (PFS), overall survival (OS), and long-term OS (LT-OS) with sunitinib in 1,059 patients, treated on clinical trials, with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Motzer, R. J.; Escudier, B.; Bukowski, R.; Rini, B. I.; Hutson, T. E.; Barrios, C. H.; Lin, X.; Fly, K.; Matczak, E.; Gore, M. E.
    European Journal of Cancer (2011)

    Fulltext@MSK | Save